Kalinin R A, Suchkov I A, Klimentova É A, Shchul'kin A V, Egorov A A
I.P. Pavlov Ryazan State Medical University of the RF Ministry of Public Health, Ryazan, Russia.
Angiol Sosud Khir. 2021;27(3):8-15. doi: 10.33529/ANGIO2021301.
This study was aimed at determining Bcl-2 and Bax proteins expression before and after reconstructive-repairing operations in patients with atherosclerosis obliterans of lower extremities and at assessing the effect of an antioxidant (vitamin E at a dose of 100 mg once daily for 1 month after surgery) on the dynamics of changes of Bcl-2 and Bax proteins in the postoperative period.
The study included a total of 60 patients with stage III-IV lower limb atherosclerosis obliterans. All patients underwent reconstructive-repairing operations on the arteries of the aortofemoral segment. After surgery the patients were divided into two groups. Group A included 30 patients who during 1 month received additionally to basic therapy vitamin E at a daily dose of 100 mg. Group B was composed of 30 patients receiving basic therapy alone according to the National guidelines of managing patients with peripheral artery disease. All patients before, on POD 1, and 1 month after surgery were subjected to venous blood test aimed at determining Bcl-2 and Bax apoptosis proteins expression by means of enzyme-linked immunosorbent assay.
In patients of groups A and B, the baseline level of Bcl-2 protein (4.75 and 4.2 ng/ml, respectively) was comparable with that in apparently healthy volunteers (5.3 ng/ml). The baseline levels of Bax protein in patients of the operated groups (26.9 and 26.0 ng/ml, respectively) were increased compared with the values in healthy volunteers (16.5 ng/ml). On POD 1 there was increased expression of Bax protein in Group A and B patients to 39.4 and 30.2 ng/ml, respectively. One month after surgery, Group B patients demonstrated a decrease in the Bcl-2 values below the baseline level - 1.1 ng/ml (p=0.003), with the Bax level continuing to increase - 36 ng/ml (p=0.004). In turn, Group A patients after 1 month were found to have increased levels of the Bcl-2 protein - 5.75 ng/ml, with the Bax level returning to the baseline values - 27.4 ng/ml.
In stage III and IV lower limb obliterating atherosclerosis, the level of the Bax proapoptoric protein was higher than that in healthy volunteers. On POD 1, there occurred increased expression of the pro-apoptotic protein Bax and activation of apoptosis markers. On the background of using vitamin E at a dose of 100 mg once daily for 1 month, there was a decrease in level of the Bax propapoptotic protein (p=0.003) and an increase in level of the anti-apoptotic Bcl-2 protein level (p=0.0007).
本研究旨在测定下肢动脉硬化闭塞症患者重建修复手术前后Bcl-2和Bax蛋白的表达情况,并评估抗氧化剂(术后1个月每天服用100mg维生素E)对术后Bcl-2和Bax蛋白变化动态的影响。
本研究共纳入60例III-IV期下肢动脉硬化闭塞症患者。所有患者均接受了主-股动脉段动脉重建修复手术。术后患者被分为两组。A组包括30例患者,在基础治疗的同时,术后1个月每天额外服用100mg维生素E。B组由30例患者组成,按照外周动脉疾病患者管理的国家指南仅接受基础治疗。所有患者在手术前、术后第1天和术后1个月均接受静脉血检测,旨在通过酶联免疫吸附测定法测定Bcl-2和Bax凋亡蛋白的表达。
A组和B组患者中,Bcl-2蛋白的基线水平(分别为4.75和4.2ng/ml)与明显健康志愿者的水平(5.3ng/ml)相当。手术组患者中Bax蛋白的基线水平(分别为26.9和26.0ng/ml)高于健康志愿者的值(16.5ng/ml)。术后第1天,A组和B组患者中Bax蛋白的表达分别增加至39.4和30.2ng/ml。术后1个月,B组患者的Bcl-2值降至基线水平以下 - 1.1ng/ml(p = 0.003),而Bax水平继续升高 - 36ng/ml(p = 0.004)。相反,A组患者在1个月后发现Bcl-2蛋白水平升高 - 5.75ng/ml,Bax水平恢复至基线值 - 27.4ng/ml。
在III期和IV期下肢闭塞性动脉硬化中,促凋亡蛋白Bax的水平高于健康志愿者。术后第1天,促凋亡蛋白Bax的表达增加,凋亡标志物激活。在每天服用100mg维生素E 1个月的背景下,促凋亡蛋白Bax的水平降低(p = 0.003),抗凋亡Bcl-2蛋白水平升高(p = 0.0007)。